首页|氨基末端脑钠肽前体水平对急性冠脉综合征合并肾功能不全患者经皮冠状动脉介入治疗临床预后影响

氨基末端脑钠肽前体水平对急性冠脉综合征合并肾功能不全患者经皮冠状动脉介入治疗临床预后影响

扫码查看
目的 探讨血浆氨基末端脑钠肽前体(NT-proBNP)水平对急性冠脉综合征(ACS)合并肾功能不全(RI)患者经皮冠状动脉介入治疗(PCI)临床预后的影响。方法 选取北部战区总医院自 2016 年 3 月至 2019 年 3 月收治的 1 608 例合并RI的ACS患者为研究对象。患者均接受PCI。根据肾功能对患者NT-proBNP水平进行校正。根据NT-proBNP未校正三分位将患者分入T1 组(n=536)、T2 组(n=536)、T3 组(n=536);根据 NT-proBNP校正三分位将患者分入 T1a组(n=536)、T2a组(n=534)、T3a组(n=538)。研究主要结局事件为患者出院后12 个月的全因死亡;次要结局事件为 12 个月的缺血事件和心源性死亡。结果 在全因死亡、缺血事件、心源性死亡方面,T2 组和T3 组的发生风险高于T1 组且T3 组的发生风险高于T2 组,同时,T2a组和T3a组的发生风险高于T1a组且T3a组的发生风险高于T2a组,差异均有统计学意义(P<0。05)。T1 组、T2 组、T3 组3 组患者在全因死亡、缺血事件中差异有统计学意义(Log-rank P<0。001);T1a组、T2a组、T3a组 3 组患者在全因死亡、缺血事件中差异也有统计学意义(Log-rank P<0。001)。NT-proBNP未校正和NT-proBNP校正预测ACS合并RI患者PCI后全因死亡的受试者工作特征曲线下面积分别为 0。764(95%可信区间 0。723~0。805)和 0。765(95%可信区间 0。724~0。806),预测缺血事件的受试者工作特征曲线下面积分别为 0。735(95%可信区间 0。689~0。780)和 0。735(95%可信区间 0。689~0。780),差异均无统计学意义(P>0。05)。结论 血浆NT-proBNP水平对ACS合并RI患者PCI后全因死亡、缺血事件具有预测价值,但校正后的NT-proBNP不能提高预测的准确性。
Effect of N-terminal pro-B-type natriuretic peptide on clinical prognosis of patients with acute coronary syndrome complicat-ed with renal insufficiency after percutaneous coronary intervention
Objective To investigate the effect of N-terminal pro-B-type natriuretic peptide(NT-proBNP)on the prognosis of patients with acute coronary syndrome(ACS)complicated with renal insufficiency(RI)after percutaneous coronary intervention(PCI).Methods 1 608 patients with ACS combined with RI admitted to General Hospital of Northern Theater Command from March 2016 to March 2019 were selected as the study objects.All patients underwent PCI.The level of NT-proBNP was corrected according to renal function.Patients were divided into T1 group(n=536),T2 group(n=536)and T3 group(n=536)according to the uncorrected NT-proBNP level tripartite,and then divided into T1a group(n=536),T2a group(n=534)and T3a group(n=538)according to the correc-ted NT-proBNP level tripartite.The primary outcome event was all-cause death at 12 months after discharge.The secondary outcome e-vents were ischemic events and cardiac death at 12 months.Results In terms of all-cause death,ischemic events and cardiac death,the risk in T2 and T3 groups was higher than that in T1 group,and the risk in T3 group was higher than that in T2 group,meanwhile,the risk in T2a and T3a groups was higher than that in T1a group,and the risk in T3a group was higher than that in T2a group,with statistical significance(P<0.05).There were significant differences in all-cause death and ischemic events in T1,T2 and T3 groups(Log-rank P<0.001).There were also significant differences in all-cause death and ischemic events in T1a,T2a and T3a groups(Log-rank P<0.001).The areas under receiver operating characteristic curves of NT-proBNP uncorrected and NT-proBNP corrected prediction of all-cause death after PCI in ACS patients with RI were 0.764(95%confidence interval 0.723-0.805)and 0.765(95%confidence in-terval 0.724-0.806),respectively,meanwhile,the areas under receiver operating characteristic curves for predicting ischemic events were 0.735(95%confidence interval 0.689-0.780)and 0.735(95%confidence interval 0.689-0.780),respectively,with no statisti-cal significance(P>0.05).Conclusion Plasma NT-proBNP level can predict all-cause death and ischemic events in ACS patients with RI after PCI,but the corrected NT-proBNP level can not improve the accuracy of prediction.

N-terminal pro-B-type natriuretic peptideRenal insufficiencyAcute coronary syndromePercutaneous coronary interventionPrognosis

母雪飞、王可心、裘淼涵、段一璇、刘道申、周尚珣、徐颖、李毅

展开 >

北部战区总医院 心血管内科,辽宁 沈阳 110016

氨基末端脑钠肽前体 肾功能不全 急性冠脉综合征 经皮冠状动脉介入治疗 预后

国家重点研发计划国家重点研发计划

2022YFC25035002022YFC2503504

2024

临床军医杂志
解放军沈阳军区卫生人员训练基地

临床军医杂志

CSTPCD
影响因子:0.465
ISSN:1671-3826
年,卷(期):2024.52(6)
  • 17